Utilization of iPSC Technologies for Drug-Induced Risk and Drug Efficacy Evaluation During Drug Development

Curr Pharm Biotechnol. 2020;21(9):750-751. doi: 10.2174/138920102109200610123205.

Author

Norimasa Miyamoto¹

Affiliation

¹ Advanced Biosignal Safety Assessment Biopharmaceutical Assessments Core Function Unit Medicine Development Center Eisai Co., Ltd. (Tsukuba Research Laboratories) 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan.

PMID: 32830622
DOI: 10.2174/138920102109200610123205

No abstract available

Publication types

Editorial